CBD Oil: Just Blowing Smoke—Or a Worthy Investment?
The CBD oil industry is certainly a subject of contention between the medical community and college-bros alike. The latter claim it a revolutionary alternative to side-effect-laden treatments of certain diseases while the former laugh it off as a pothead’s argument to legitimize a potted-plant lifestyle.
But regardless of opinion, CBD oil distributing companies have sprouted like mushrooms across the US, all eager to jump in its growing spotlight—and it seems to be catching across the globe faster than burning twine.
So, What is CBD Oil?
According to Project CBD, “Cannabidiol (CBD) is a naturally occurring compound found in the resinous flower of cannabis [known as the marijuana plant]” It is distinct from THC, the active chemical that gives the user that “bro, let’s hit up that 7-11 and get at least 30 bags of Chili-Cheese-Fritos” experience.
How is it consumed?
CBD is sold and consumed in a diversity of ways including vape oil, sprays, applicable oil and even in pill-form.
Is it legal?
It’s legal in 30 the states where recreational and medicinal administration of marijuana is protected under law.
Why Are People Talking About It?
Advocates of CBD claim it can help treat a garden variety of medical problems such as epilepsy, anxiety, diabetes, Alzheimer’s, blood pressure—among many others.
Many point to a few studies that suggest CBD can serve as an alternative to those looking to avoid the nasty side-effects of conventional medicine.
Though the studies imply a lot of hope and promise for CBD effectiveness, the results are occasionally conflicting and the studies themselves are somewhat sparse due to lack of funding. Of course, that hasn’t stopped the budding demand for CBD products from across the cosmos.
Should I Invest in CBD?
Short Answer: Heck yeah, man. Here are three reasons:
BUT note that there no guarantee of the performance of any stock of any kind. It’s best to consult an investment advisor before making any major decisions on your investment.
1. Stocks are Poised to Skyrocket— The Hemp Business Journal boasts that CBD will be a 2.1-billion-dollar market in 2020—some predict that number to be even higher.
2. The Farm Bill is paving the road for CBD success—The 2018 Farm Bill “offers federal acceptance for products containing CBD oil…[and] provides protection for farmers who grow the crops to make these products.”
3. Legalization is Around the Corner—Cannabis is now fully legal in 9 states and Washington D.C. — and will likely continue given its deep integration in society and unwavering presence in the political spectrum.
Where Should I Invest?
Here are 3 companies that seem to be attracting some eyeballs. They also have a pretty good stock performance for at least the last 5 years.
1. Aurora Cannabis’ share price has shot up 90% so far in 2019, which is phenomenal. And according to The Motley Fool, its capacity (that is, the quantity of sellable goods) is projected to double in order to meet the seemingly never-ending demand.
2. Canopy Growth Corporation is the first publicly traded cannabis company, not to mention they are part of the S&P/TSX Composite Index—one of the only cannabis corporations on a global market stock.
3. GW Pharmaceuticals rolled out the very first cannabis-based prescription called Sativex, an epilepsy treatment. It has now been approved in over 25 countries and the company continues to further research on the overall effectiveness of the cannabis plant.
Remember, all stocks are subject to volatility, including those listed above.